[Expression of vascular endothelial growth factor A and C in human breast cancer and their significance]

Vascular endothelial growth factor (VEGF) family is related to angiogenesis. VEGF-A and VEGF-C are closely related to tumorigenesis and lymphatic metastasis. This study was to detect the expression of VEGF-A and VEGF-C in breast cancer, and explore their correlation to cell proliferation, microvessel density (MVD), and lymphatic metastasis of breast cancer.

The expression of VEGF-A, VEGF-C, proliferating cell nuclear antigen (PCNA), and CD34 in 98 samples of breast cancer were detected by SP immunohistochemistry.

The positive rate of VEGF-A was 85.7%; that of VEGF-C was 90.8%. The positive rates of VEGF-A and VEGF-C were significantly higher in cancers with lymph node metastasis than in cancers without lymph node metastasis (P<0.05). The positive rate of PCNA was 98.0%; its expression level was increased with the expression levels of VEGF-A and VEGF-C (r=0.432, P=0.000; r=0.294, P=0.001). MVD was significantly higher in cancers with lymph node metastasis than in cancers without lymph node metastasis(64.26+/-26.40 vs. 50.29+/-29.35, P<0.05). MVD was positively correlated to the expression of VEGF-A (r=0.327, P<0.001), but had no correlation to VEGF-C (r=0.123, P>0.05).

VEGF-A mainly mediates angiogenesis, cell proliferation, and metastasis of human breast cancer. VEGF-C promotes cell proliferation of human breast cancer; it is correlated to lymph node metastasis, but has no correlation to MVD.